Premium
Is there a role for antiangiogenic therapy, bevacizumab, in the treatment of recurrent digestive bleeding due to angiodysplasia in Glanzmann's thrombasthenia?
Author(s) -
Barré A.,
Dréanic J.,
Flaujac C.,
RousselRobert V.,
Stieltjes N.,
CombeMarzelle S.,
Coriat R.,
Horellou MH.
Publication year - 2016
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/hae.12977
Subject(s) - medicine , glanzmann's thrombasthenia , haemophilia , thrombasthenia , general surgery , pediatrics , platelet , platelet aggregation
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom